Estradiol/drospirenone

Source: Wikipedia, the free encyclopedia.
Estradiol/drospirenone
Antimineralocorticoid; Antiandrogen
Legal status
Legal status
Identifiers
CAS Number

Estradiol/drospirenone (E2/DRSP), sold under the brand name Angeliq, is a

postmenopausal women.[1][2][3] It is taken by mouth and contains 0.5 to 1 mg E2 and 0.25 to 0.5 mg DRSP per tablet.[1] The medication was approved in the United States in 2005.[1] It is marketed widely throughout the world.[4]

See also

References

  1. ^ a b c "ANGELIQ (drospirenone and estradiol) Prescribing Information" (PDF). Bayer HealthCare Pharmaceuticals Inc. U.S. Food and Drug Administration. February 2012.
  2. ^ "Estradiol/Drospirenone - Bayer HealthCare Pharmaceuticals". AdisInsight.
  3. S2CID 7305124
    .
  4. ^ "Drospirenone and Estradiol: Uses, Side Effects & Warnings".

External links